"Tufts Medical Center is an exceptional, not-for-profit, 415-bed academic medical center that is home to both a full-service hospital for adults and Floating Hospital for Children. Conveniently located in downtown Boston, the Medical Center is the principal teaching hospital for Tufts University School of Medicine. Floating Hospital for Children is the full-service children's hospital of Tufts Medical Center and the principal pediatric teaching hospital of Tufts University School of Medicine. Tufts Medical Center is affiliated with the New England Quality Care Alliance, a network of more than 1,800 physicians throughout Eastern Massachusetts."

During the past decade, Tufts Medical Center; Ophthalmology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tufts Medical Center; Ophthalmology" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Boston Image Reading Center" with 2 trials sponsored, "Tufts Medical Center" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Robert Feldman" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tufts Medical Center; Ophthalmology" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tufts Medical Center; Ophthalmology" are "Diabetic Macular Edema" (2 trials), "Dry Macular Degeneration" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Serous Chorioretinopathy" (1 trials) and "Dry Eye" (1 trials). Many other conditions were trialed in "Tufts Medical Center; Ophthalmology" in a lesser frequency.

Most popular intervention types in "Tufts Medical Center; Ophthalmology" are "Drug" (8 trials), "Procedure" (4 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (5 trials), "Sham Procedure" (5 trials), "Aflibercept" (3 trials), "SS-OCT imaging" (2 trials) and "Ahmed Model FP7 Flexible Plate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tufts Medical Center; Ophthalmology" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Tufts Medical Center; Ophthalmology". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Tufts Medical Center; Ophthalmology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tufts Medical Center; Ophthalmology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".